The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K<sup>+</sup>-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure.
作者:
主题词
血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);双盲法(Double-Blind Method);心力衰竭(Heart Failure);人类(Humans);高钾血症(Hyperkalemia);离子交换树脂类(Ion Exchange Resins);肾功能不全, 慢性(Renal Insufficiency, Chronic);肾素-血管紧张素系统(Renin-Angiotensin System);硅酸盐类(Silicates);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1186/s12882-021-02439-2
PMID
34229607
发布时间
2024-03-27
- 浏览9

BMC nephrology
254页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文